Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets
- PMID: 858010
- PMCID: PMC1667754
- DOI: 10.1111/j.1476-5381.1977.tb07735.x
Aspirin at therapeutic concentrations does not affect 5-hydroxytryptamine uptake by platelets
Abstract
Aspirin at therapeutic concentrations does not inhibit the uptake of 5-hydroxytryptamine (5-HT) by blood platelets nor induce release of 5-HT from platelets, although platelet aggregation responses to collagen and arachidonic acid (which are dependent on platelet prostaglandin synthesis) are abolished. This does not support an earlier claim that aspirin's effects on platelet function include inhibition of 5-HT transport.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
